Financhill
Back

Iterum Therapeutics PLC Quote, Financials, Valuation and Earnings

Buy
52

ITRM
Iterum Therapeutics PLC

Last Price:
1.37
Seasonality Move:
-17.48%

7 Day Trial

ALL ACCESS PASS

$ 7

Iterum Therapeutics PLC Price Quote

$1.37
-0.04 (-7.43%)
(Updated: May 18, 2024 at 5:46 AM ET)

Iterum Therapeutics PLC Key Stats

Buy
52
Iterum Therapeutics PLC (ITRM) is a Buy

Day range:
$1.36 - $1.53
52-week range:
$0.62 - $2.50
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
26.92
P/B ratio:
0%

Volume:
176.8K
Avg. volume:
122.2K
1-year change:
25.89%
Market cap:
$23.3M
Revenue:
$0
EPS:
$-2.65

How Much Does Iterum Therapeutics PLC Make?

Data Unavailable

Is Iterum Therapeutics PLC Growing As A Company?

Data Unavailable

Iterum Therapeutics PLC Stock Price Performance

What Is Iterum Therapeutics PLC 52-Week High & Low?

Iterum Therapeutics PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Iterum Therapeutics PLC?

Is Iterum Therapeutics PLC Cash Flow Positive?

  • What Is ITRM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$42.8M
  • What Is Iterum Therapeutics PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $8M
  • What Is Iterum Therapeutics PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $25.4M

Iterum Therapeutics PLC Return On Invested Capital

Data Unavailable

Iterum Therapeutics PLC Earnings Date & Stock Price

Iterum Therapeutics PLC Competitors

Iterum Therapeutics PLC Dividend Yield

Data Unavailable

Iterum Therapeutics PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 29.63%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 6.50
Upside from Last Price: 360.99%

Major Shareholders

  • How many ITRM shares are owned by institutional investors?
    1.3M ITRM shares are owned by institutional investors
  • How many ITRM shares are owned by insiders?
    322.3K ITRM shares are owned by insiders